Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 26, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

[Adult medulloblastomas: our experience].

R Rodríguez-Mena1, R A Barbella-Aponte, J M Gallego-Sánchez

  • 1Servicio de Neurocirugía, Servicio de Anatomía Patológica, Consorcio Hospital General Universitario de Valencia, Valencia, España. ruben.rod@gmail.com

Neurocirugia (Asturias, Spain)
|December 15, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shredded vs. pledget teflon in microvascular decompression for trigeminal neuralgia: a retrospective comparative study.

British journal of neurosurgery·2026
Same author

[Linear accelerator radiosurgery for the treatment of vestibular schwannoma].

Revista de neurologia·2011
Same author

Paroxysmal radiculopathy associated to raised CSF pressure in a patient with spinal meningeal cysts.

Clinical neurology and neurosurgery·2011
Same author

[Lumboperitoneal shunt in an outpatient setting for the treatment of chronic hydrocephalus in adults. A study and follow-up of 30 cases].

Revista de neurologia·2009
Same author

[Tension pneumocephalus in a patient with a scalp wound and ventriculo-peritoneal shunt: case report and literature review].

Neurocirugia (Asturias, Spain)·2009
Same author

Fatal outcome related to carmustine implants in glioblastoma multiforme.

Acta neurochirurgica·2007
Same journal

[Development of an integrated solution for patients with neurostimulator for chronic pain in times of COVID-19: A mobile application with a support center].

Neurocirugia (Asturias, Spain)·2022
Same journal

[Endoscopic endonasal surgery during COVID-19 pandemic: Management guideline].

Neurocirugia (Asturias, Spain)·2021
Same journal

Neurocirugia (Asturias, Spain)·2017
Same journal

[Antithrombotic treatment consensus protocol (anticoagulation and antiplatelet therapy) during the perioperative and periprocedural period in neurosurgery].

Neurocirugia (Asturias, Spain)·2017
Same journal

[Prognostic and predictive factors in high-grade gliomas. Experience at our institution].

Neurocirugia (Asturias, Spain)·2017
Same journal

Lumbar pseudo-tail associated with dermal sinus - A case report.

Neurocirugia (Asturias, Spain)·2017
See all related articles

Adult medulloblastomas are rare cerebellar tumors. Aggressive surgical resection followed by radiotherapy and chemotherapy offers a favorable prognosis, with a 5-year survival rate of 84%.

Area of Science:

  • Neuro-oncology
  • Surgical oncology
  • Radiation oncology

Context:

  • Medulloblastomas are rare, malignant cerebellar tumors primarily affecting children.
  • Adult medulloblastomas present unique treatment challenges and outcomes.
  • This study details institutional experience with adult medulloblastoma management.

Purpose:

  • To describe the clinical, radiological, and therapeutic outcomes of adult medulloblastomas.
  • To evaluate the efficacy of multimodal treatment including surgery, radiotherapy, and chemotherapy.
  • To identify prognostic factors and survival rates in adult medulloblastoma patients.

Summary:

  • Retrospective analysis of 11 adult medulloblastoma patients treated between 1984-2010.
  • Gross total surgical resection (72.7%) followed by craniospinal radiotherapy and chemotherapy (cisplatin and etoposide) was the standard treatment.

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

Related Experiment Videos

Last Updated: May 26, 2026

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

  • Median follow-up of 35.2 months revealed a 36.4% relapse rate, managed with further surgery and chemotherapy. Mean survival was 100.3 months, with 5- and 8-year overall survival rates of 84% and 56% respectively.

    • Impact:

    • Highlights the critical role of gross total surgical resection in adult medulloblastoma treatment.
    • Emphasizes the importance of timely oncological therapy, particularly radiotherapy, post-surgery.
    • Provides valuable data on survival outcomes and relapse patterns for this rare adult malignancy.